FDA’s Social Media Guidance: As Industry Waits, How Watchful Should It Be?
This article was originally published in The Pink Sheet Daily
Executive Summary
In the absence of clear policy from the agency, GSK keeps careful eyes on Facebook, but experts disagree on the extent to which drug companies are required to actively monitor social media sites.